Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2004 Apr;75(4):545–547. doi: 10.1136/jnnp.2003.018309

The L-dopa response in vascular parkinsonism

J Zijlmans 1, R Katzenschlager 1, S Daniel 1, A Lees 1
PMCID: PMC1739027  PMID: 15026493

Abstract

Objective: To determine whether a positive L-dopa response in vascular parkinsonism (VP) is correlated with the presence of nigrostriatal pathology due to either vascular damage or neuronal cell loss.

Methods: Seventeen patients with pathologically confirmed VP were selected from the pathological collection of the Queen Square Brain Bank for Neurological Disorders, and their L-dopa response during life was compared with the presence of macroscopic vascular damage in the nigrostriatal pathway and microscopic substantia nigra cell loss.

Results: Ten of the twelve patients with a good or excellent response had macroscopic infarcts or lacunae caused by enlarged perivascular spaces in the basal ganglia or microscopic neuronal cell loss in the substantia nigra. In contrast, only one of the five patients with a moderate or no response had lacunae in the putamen, and none had lacunar infarcts or substantia nigra cell loss.

Conclusion: These results suggest that a substantial number of patients with clinically suspected VP may respond with benefit to dopaminergic therapy, especially those with lesions in or close to the nigrostriatal pathway.

Full Text

The Full Text of this article is available as a PDF (140.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bernheimer H., Birkmayer W., Hornykiewicz O., Jellinger K., Seitelberger F. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci. 1973 Dec;20(4):415–455. doi: 10.1016/0022-510x(73)90175-5. [DOI] [PubMed] [Google Scholar]
  2. Boecker H., Weindl A., Leenders K., Antonini A., Kuwert T., Kruggel F., Grafin von Einsiedel H., Conrad B. Secondary parkinsonism due to focal substantia nigra lesions: a PET study with [18F]FDG and [18F]fluorodopa. Acta Neurol Scand. 1996 Jun;93(6):387–392. doi: 10.1111/j.1600-0404.1996.tb00015.x. [DOI] [PubMed] [Google Scholar]
  3. Chang C. M., Yu Y. L., Ng H. K., Leung S. Y., Fong K. Y. Vascular pseudoparkinsonism. Acta Neurol Scand. 1992 Dec;86(6):588–592. doi: 10.1111/j.1600-0404.1992.tb05492.x. [DOI] [PubMed] [Google Scholar]
  4. Demirkiran M., Bozdemir H., Sarica Y. Vascular parkinsonism: a distinct, heterogeneous clinical entity. Acta Neurol Scand. 2001 Aug;104(2):63–67. doi: 10.1034/j.1600-0404.2001.104002063.x. [DOI] [PubMed] [Google Scholar]
  5. Dubinsky R. M., Jankovic J. Progressive supranuclear palsy and a multi-infarct state. Neurology. 1987 Apr;37(4):570–576. doi: 10.1212/wnl.37.4.570. [DOI] [PubMed] [Google Scholar]
  6. FitzGerald P. M., Jankovic J. Lower body parkinsonism: evidence for vascular etiology. Mov Disord. 1989;4(3):249–260. doi: 10.1002/mds.870040306. [DOI] [PubMed] [Google Scholar]
  7. Forno L. S. Reaction of the substantia nigra to massive basal ganglia infarction. Acta Neuropathol. 1983;62(1-2):96–102. doi: 10.1007/BF00684925. [DOI] [PubMed] [Google Scholar]
  8. Fénelon G., Houéto J. L. Unilateral parkinsonism following a large infarct in the territory of the lenticulostriate arteries. Mov Disord. 1997 Nov;12(6):1086–1090. doi: 10.1002/mds.870120642. [DOI] [PubMed] [Google Scholar]
  9. Ikeda K., Kotabe T., Kanbashi S., Kinoshita M. Parkinsonism in lacunar infarcts of the basal ganglia. Eur Neurol. 1996;36(4):248–249. doi: 10.1159/000117266. [DOI] [PubMed] [Google Scholar]
  10. Jellinger K. A. Parkinsonism due to Binswanger's subcortical arteriosclerotic encephalopathy. Mov Disord. 1996 Jul;11(4):461–462. doi: 10.1002/mds.870110428. [DOI] [PubMed] [Google Scholar]
  11. Lee M. S., Lee S. A., Heo J. H., Choi I. S. A patient with a resting tremor and a lacunar infarction at the border between the thalamus and the internal capsule. Mov Disord. 1993 Apr;8(2):244–246. doi: 10.1002/mds.870080234. [DOI] [PubMed] [Google Scholar]
  12. Leenders K. L., Salmon E. P., Tyrrell P., Perani D., Brooks D. J., Sager H., Jones T., Marsden C. D., Frackowiak R. S. The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease. Arch Neurol. 1990 Dec;47(12):1290–1298. doi: 10.1001/archneur.1990.00530120034007. [DOI] [PubMed] [Google Scholar]
  13. Mark M. H., Sage J. I., Walters A. S., Duvoisin R. C., Miller D. C. Binswanger's disease presenting as levodopa-responsive parkinsonism: clinicopathologic study of three cases. Mov Disord. 1995 Jul;10(4):450–454. doi: 10.1002/mds.870100408. [DOI] [PubMed] [Google Scholar]
  14. Murrow R. W., Schweiger G. D., Kepes J. J., Koller W. C. Parkinsonism due to a basal ganglia lacunar state: clinicopathologic correlation. Neurology. 1990 Jun;40(6):897–900. doi: 10.1212/wnl.40.6.897. [DOI] [PubMed] [Google Scholar]
  15. Poirier J., Derouesne C. Cerebral lacunae. A proposed new classification. Clin Neuropathol. 1984 Nov-Dec;3(6):266–266. [PubMed] [Google Scholar]
  16. Quinn N., Parkes D., Janota I., Marsden C. D. Preservation of the substantia nigra and locus coeruleus in a patient receiving levodopa (2 kg) plus decarboxylase inhibitor over a four-year period. Mov Disord. 1986;1(1):65–68. doi: 10.1002/mds.870010109. [DOI] [PubMed] [Google Scholar]
  17. Remy P., de Recondo A., Defer G., Loc'h C., Amarenco P., Planté-Bordeneuve V., Dao-Castellana M. H., Bendriem B., Crouzel C., Clanet M. Peduncular 'rubral' tremor and dopaminergic denervation: a PET study. Neurology. 1995 Mar;45(3 Pt 1):472–477. doi: 10.1212/wnl.45.3.472. [DOI] [PubMed] [Google Scholar]
  18. Tison F., Duché B., Loiseau P. Syndrome hémiparkinsonien vasculaire. Rev Neurol (Paris) 1993;149(10):565–567. [PubMed] [Google Scholar]
  19. Tolosa E. S., Santamaría J. Parkinsonism and basal ganglia infarcts. Neurology. 1984 Nov;34(11):1516–1518. doi: 10.1212/wnl.34.11.1516. [DOI] [PubMed] [Google Scholar]
  20. Winikates J., Jankovic J. Clinical correlates of vascular parkinsonism. Arch Neurol. 1999 Jan;56(1):98–102. doi: 10.1001/archneur.56.1.98. [DOI] [PubMed] [Google Scholar]
  21. Winikates J., Jankovic J. Vascular progressive supranuclear palsy. J Neural Transm Suppl. 1994;42:189–201. doi: 10.1007/978-3-7091-6641-3_15. [DOI] [PubMed] [Google Scholar]
  22. Yamanouchi H., Nagura H. Neurological signs and frontal white matter lesions in vascular parkinsonism. A clinicopathologic study. Stroke. 1997 May;28(5):965–969. doi: 10.1161/01.str.28.5.965. [DOI] [PubMed] [Google Scholar]
  23. Zijlmans J. C., Thijssen H. O., Vogels O. J., Kremer H. P., Poels P. J., Schoonderwaldt H. C., Merx J. L., van 't Hof M. A., Thien T., Horstink M. W. MRI in patients with suspected vascular parkinsonism. Neurology. 1995 Dec;45(12):2183–2188. doi: 10.1212/wnl.45.12.2183. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES